Atlas Trials

Omega-3 Fatty Acid Deficiency Replacement in Early Schizophrenia

Clinical trial NCT00585390 · COMPLETED

Trial details

NCT number
NCT00585390
Sponsor
University of Cincinnati
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
SchizophreniaFatty Acid Deficiency
Start date
2008-01-01
Primary completion
2009-11-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.